Li Sun
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 1%
- Angiogenesis and VEGF in Cancer
- Fibroblast Growth Factor Research
- Epigenetics and DNA Methylation
- Developmental Biology and Gene Regulation
- PI3K/AKT/mTOR signaling in cancer
- Mitochondrial Function and Pathology
Papers in
-
- Angiogenesis and VEGF in Cancer 11
- Epigenetics and DNA Methylation 9
- Cancer therapeutics and mechanisms 7
- Ubiquitin and proteasome pathways 6
- 14-3-3 protein interactions 6
-
- Cancer, Hypoxia, and Metabolism 26
- Cancer-related molecular mechanisms research 7
- Co-authors
- Gerald McMahon (8 shared papers)Cho Tang (9 shared papers)Danshen Zhang (1 shared paper)Chunyan Guo (1 shared paper)Xueping Chen (1 shared paper)Shengtao Yuan (65 shared papers)Peter Hirth (2 shared papers)Stevan R. Hubbard (3 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (6 papers)Oncology Reports (6 papers)Chinese Journal of Natural Medicines (5 papers)European Journal of Pharmacology (4 papers)Cell Death and Disease (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Li Sun
120 papers receiving 7.6k citations
Li Sun's Hit Papers
Peers
Comparison fields: 5 of 139
- Cancer Research 1.3k
- Molecular Biology 4.2k
- Oncology 1.4k
- Toxicology 130
- Immunology and Allergy 201
Countries citing papers authored by Li Sun
This map shows the geographic impact of Li Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Sun more than expected).
Fields of papers citing papers by Li Sun
This network shows the impact of papers produced by Li Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Sun. The network helps show where Li Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oxidative stress, mitochondrial damage and neurodegenerative diseases. Hit paper breakdown → | 2013 | 1069 |
| 2 | Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with Inhibitors Hit paper breakdown → | 1997 | 961 |
| 3 | SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Hit paper breakdown → | 1999 | 885 |
| 4 | SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling Hit paper breakdown → | 2000 | 520 |
| 5 | 1998 | 430 | |
| 6 | SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. | 2000 | 401 |
| 7 | 1999 | 213 | |
| 8 | 2018 | 137 | |
| 9 | 2018 | 133 | |
| 10 | 2018 | 106 | |
| 11 | 2000 | 99 | |
| 12 | Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. | 2003 | 93 |
| 13 | 2021 | 87 | |
| 14 | 2017 | 84 | |
| 15 | 2012 | 83 | |
| 16 | 2017 | 77 | |
| 17 | 2010 | 74 | |
| 18 | 2017 | 74 | |
| 19 | 2021 | 68 | |
| 20 | 2021 | 68 |
About Li Sun
Li Sun is a scholar working on Molecular Biology, Cancer Research, Oncology, Pharmacology and Pathology and Forensic Medicine, having authored 124 papers that have together received 7.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (26 papers), Angiogenesis and VEGF in Cancer (11 papers), Epigenetics and DNA Methylation (9 papers), Cancer-related molecular mechanisms research (7 papers), Cancer therapeutics and mechanisms (7 papers), Ubiquitin and proteasome pathways (6 papers), 14-3-3 protein interactions (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (4.2k citations), Oncology (1.4k citations), Toxicology (130 citations) and Immunology and Allergy (201 citations). Li Sun has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Gerald McMahon, Cho Tang, Danshen Zhang, Chunyan Guo, Xueping Chen, Shengtao Yuan, Peter Hirth, Stevan R. Hubbard, Moosa Mohammadi and Joseph Schlessinger. Their work appears in journals such as Biomedicine & Pharmacotherapy, Oncology Reports, Chinese Journal of Natural Medicines, European Journal of Pharmacology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.